Abstract
Literature on the relationship between corporate governance and corporate social responsibility (CSR) in the critical healthcare sector is limited. This study fills this void by investigating the impact of different independent directors and CEO power on CSR performance in the US healthcare sector. Using the panel data analysis method, this study demonstrates the power disparity between the CEO and the board can affect CSR performance. The results provide insights regarding the board effectiveness in both advising and monitoring the management. The findings provide empirical evidence for healthcare management policymakers to reconsider the factors that influence the appointment of board directors.
Similar content being viewed by others
Data availability
Data is available upon request.
Notes
Refinitive is Thomson Reuter's former Financial and Risk business, now a part of LSEG.
References
Abels PB, Martelli JT (2013) CEO duality: how many hats are too many? Corp Gov Int J Bus Soc 13(2):135–147
Adams RB, Ferreira D (2007) A theory of friendly boards. J Finance 62(1):217–250
Ahmad NBJ, Rashid A, Gow J (2017) CEO duality and corporate social responsibility reporting: evidence from Malaysia. Corp Ownersh Control 14:69–81
Alexander JA, Lee SYD (2006) Does governance matter? Board configuration and performance in not-for-profit hospitals. Milbank Q 84(4):733–758
Ali W, Frynas JG, Mahmood Z (2017) Determinants of corporate social responsibility (CSR) disclosure in developed and developing countries: a literature review. Corp Soc Responsib Environ Manag 24(4):273–294
Ali HY, Danish RQ, Asrar-ul-Haq M (2020) How corporate social responsibility boosts firm financial performance: the mediating role of corporate image and customer satisfaction. Corp Soc Responsib Environ Manag 27(1):166–177
Bai G (2013) How do board size and occupational background of directors influence social performance in for-profit and non-profit organizations? Evidence from California hospitals. J Bus Ethics 118(1):171–187
Bainbridge SM (2012) Corporate governance after the financial crisis. Oxford University Press, Oxford
Basco R, Campopiano G, Calabrò A, Kraus S (2019) They are not all the same! Investigating the effect of executive versus non-executive family board members on firm performance. J Small Bus Manag 57:637–657
Bax K, Paterlini S (2022) Environmental social governance information and disclosure from a company perspective: a structured literature review. Int J Bus Perform Manag 23(3):304–322
Baysinger BD, Butler HN (1985) Corporate governance and the board of directors: performance effects of changes in board composition. J Law Econ Organ 1(1):101–124
Behl A, Kumari PSR, Makhija H, Sharma D (2022) Exploring the relationship of ESG score and firm value using cross-lagged panel analyses: case of the Indian energy sector. Ann Oper Res 313(1):231–256
Benjamin S, Mansi M, Pandey R (2020) Board gender composition, board independence and sustainable supply chain responsibility. Account Finance 60(4):3305–3339
Bose S, Ali MJ, Hossain S, Shamsuddin A (2022) Does CEO-audit committee/board interlocking matter for corporate social responsibility? J Bus Ethics 179(3):819–847
Braverman B (2021) Chair and CEO: to split or not to split? Directors and Boards. https://www.directorsandboards.com/articles/singlechair-and-ceo-split-or-not-split. Assessed 5 July 2022
Brickley JA, Van Horn RL, Wedig GJ (2010) Board composition and nonprofit conduct: evidence from hospitals. J Econ Behav Organ 76(2):196–208
Bruynseels L, Cardinaels E (2014) The audit committee: management watchdog or personal friend of the CEO? TAR 89(1):113–145
Bugbee M (2019) Intercapitalist maneuvers and the ICD-10 transition: the instrumental role of the state in the corporate governance of US health care. Int J Health Serv 49(3):457–475
Camilleri MA (2017) Corporate sustainability and responsibility: creating value for business, society and the environment. Asian J Sustain Soc Responsib 2(1):59–74
Cardinaels E (2009) Governance in non-for-profit hospitals: effects of board members’ remuneration and expertise on CEO compensation. Health Policy 93(1):64–75
Carroll AB, Shabana KM (2010) The business case for corporate social responsibility: a review of concepts, research and practice. Int J Manag Rev 12(1):85–105
Cucari N, Esposito de Falco S, Orlando B (2018) Diversity of board of directors and environmental social governance: evidence from Italian listed companies. Corp Soc Responsib Environ Manag 25(3):250–266
Cullinan CP, Mahoney L, Roush PB (2019) Directors and corporate social responsibility: joint consideration of director gender and the director’s role. Soc Environ Account J 39(2):100–123
Dahl R (2010) Greenwashing: do you know what you’re buying? Environ Health Perspect 118(6):a246–a252
Dalton DR, Daily CM, Ellstrand AE, Johnson JL (1998) Meta-analytic reviews of board composition, leadership structure, and financial performance. Strateg Manag J 19(3):269–290
Dalton DR, Hitt MA, Certo ST, Dalton CM (2007) The fundamental agency problem and its mitigation: independence, equity, and the market for corporate control. Acad Manag Ann 1(1):1–64
D’Amato A, Falivena C (2020) Corporate social responsibility and firm value: do firm size and age matter? Empirical evidence from European listed companies. Corp Soc Responsib Environ Manag 27(2):909–924
De Villiers C, Naiker V, Van Staden CJ (2011) The effect of board characteristics on firm environmental performance. J Manag 37(6):1636–1663
Devinney TM, Schwalbach J, Williams CA (2013) Corporate social responsibility and corporate governance: comparative perspectives. Corp Gov Int Rev 21(5):413–419
Duchin R, Matsusaka JG, Ozbas O (2010) When are outside directors effective? J Financ Econ 96(2):195–214
Duru A, Iyengar RJ, Zampelli EM (2016) The dynamic relationship between CEO duality and firm performance: the moderating role of board independence. J Bus Res 69(10):4269–4277
Eberhardt-Toth E (2017) Who should be on a board corporate social responsibility committee? J Clean Prod 140:1926–1935
Eckelman MJ, Huang K, Lagasse R, Senay E, Dubrow R, Sherman JD (2020) Health care pollution and public health damage in the United States: an update: study examines health care pollution and public health damage in the United States. Health Aff 39(12):2071–2079
Eduardo DG, Aguilera-Caracuel J (2021) Environmental, social and governance (ESG) scores and financial performance of multilatinas: moderating effects of geographic international diversification and financial slack. J Bus Ethics 168(2):315–334
Eeckloo K, Van Herck G, Van Hulle C, Vleugels A (2004) From corporate governance to hospital governance: authority, transparency and accountability of Belgian non-profit hospitals’ board and management. Health Policy 68(1):1–15
Eisenhardt KM (1989) Agency theory: an assessment and review. Acad Manag Rev 14(1):57–74
Endrikat J, De Villiers C, Guenther TW, Guenther EM (2021) Board characteristics and corporate social responsibility: a meta-analytic investigation. Bus Soc 60(8):2099–2135
Fallah MA, Mojarrad F (2019) Corporate governance effects on corporate social responsibility disclosure: empirical evidence from heavy-pollution industries in Iran. Soc Responsib J 15(2):208–225
Fama EF, Jensen MC (1983) Separation of ownership and control. J Law Econ 26(2):301–325
Finkelstein S, Hambrick DC (1996) Strategic leadership: top executives and their effects on organizations. West Publishing Company, Minneapolis
Gerged AM (2021) Factors affecting corporate environmental disclosure in emerging markets: the role of corporate governance structures. Bus Strategy Environ 30(1):609–629
Goergen M (2021) CEO Duality: for better and for worse. Business and Finance. IE University, 27 April. https://www.ie.edu/insights/articles/ceo-duality/. Accessed 5 July 2022
Goergen M, Limbach P, Scholz-Daneshgari M (2020) Firms’ rationales for CEO duality: evidence from a mandatory disclosure regulation. J Corp Finance 65:101770–101829
Greene, W (2018) Econometric Analysis (8th ed.) London, UK: Pearson
Greenough WC, Clapman PC (1980) Role of independent directors in corporate governance. Notre Dame Law 56:916–925
Guo L, Masulis RW (2015) Board structure and monitoring: new evidence from CEO turnovers. Rev Financ Stud 28(10):2770–2811
Haddiya I, Janfi T, Guedira M (2020) Application of the concepts of social responsibility, sustainability, and ethics to healthcare organizations. Risk Manag Healthc Policy 13:1029–1033
Harvard Chan School News on Twitter (2020) https://www.hsph.harvard.edu/news/hsph-in-the-news/the-most-expensive-health-care-system-in-the-world/. Assessed 10 Oct 2022
Hasan MT, Molla MS, Khan F (2019) Effect of board and audit committee characteristics on profitability: evidence from pharmaceutical and chemical industries in Bangladesh. Financ Econ Rev 1(1):64–76
Hohman M (2020) Why is health care so expensive in the United States? https://www.today.com/tmrw/why-healthcare-so-expensive-united-states-t192119. Assessed 15 July 2022
Hoitash U (2011) Should independent board members with social ties to management disqualify themselves from serving on the board? J Bus Ethics 99(3):399–423
Hong KS, Lee D (2018) Impact of operational innovations on customer loyalty in the healthcare sector. Serv Bus 3:575–600
Hussain N, Rigoni U, Orij RP (2018) Corporate governance and sustainability performance: analysis of triple bottom line performance. J Bus Ethics 149(2):411–432
Hwang BH, Kim S (2009) It pays to have friends. J Financ Econ 93(1):138–158
Jamali D, Hallal M, Abdallah H (2010) Corporate governance and corporate social responsibility: evidence from the healthcare sector. Corp Gov Int J Bus Soc 10(5):590–602
Kang E, Zardkoohi A (2005) Board leadership structure and firm performance. Corp Gov Int Rev 13(6):785–799
Kaymak T, Bektas E (2017) Corporate social responsibility and governance: information disclosure in multinational corporations. Corp Soc Responsib Environ Manag 24(6):555–569
Khan M, Ajmal M, Hussain M, Helo P (2018) Barriers to social sustainability in the health-care industry in the UAE. Int J Organ Anal 26(3):450–469
Khedmati M, Sualihu MA, Yawson A (2020) CEO–director ties and labor investment efficiency. J Corp Finance 65:101492–101498
Kramarz F, Thesmar D (2013) Social networks in the boardroom. J Eur Econ Assoc 11(4):780–807
Krause R, Semadeni M, Cannella AA Jr (2014) CEO duality: a review and research agenda. J Manag 40(1):256–286
Krishnan GV, Raman KK, Yang K, Yu W (2011) CFO/CEO–board social ties, Sarbanes–Oxley, and earnings management. Account Horiz 25(3):537–557
Kuzey C, Fritz MM, Uyar A, Karaman AS (2022) Board gender diversity, CSR strategy, and eco-friendly initiatives in the transportation and logistics sector. Int J Prod Econ 247:108436–108463
Kuzmina J, Lindemane M (2017) ESG investing: new challenges and new opportunities. J Bus Manag 14:85–98
Latapí AM, Jóhannsdóttir L, Davídsdóttir B (2019) A literature review of the history and evolution of corporate social responsibility. Int J Corp Soc Responsib 4(1):1–23
Lee SM, Lee DH (2022) Effects of healthcare quality management activities and sociotechnical systems on internal customer experience and organizational performance. Serv Bus 16:1–28
Lewis M (2006) Governance and corruption in public health care systems. Center for Global Development working paper (78)
Lewis M (2007) Informal payments and the financing of health care in developing and transition countries. Health Aff 26(4):984–997
Li F, Li T, Minor D (2016) CEO power, corporate social responsibility, and firm value: a test of agency theory. Int J Manag Finance 12(5):611–628
Liao L, Luo L, Tang Q (2015) Gender diversity, board independence, environmental committee and greenhouse gas disclosure. Br Account Rev 47(4):409–424
Limbu YB, Pham L, Mann M (2019) Corporate social responsibility and hospital brand advocacy: mediating role of trust and patient–hospital identification and moderating role of hospital type. Int J Pharm Healthc Mark 14(1):159–174
Lorgnier NGA, Su C, O’Rourke SM (2022) Brands’ perceived sustainable development goals: index development and applications with professional sport teams and fast-food brands. Serv Bus 16:125–157
Lu LW (2021) The moderating effect of corporate governance on the relationship between corporate sustainability performance and corporate financial performance. Int J Discl Gov 18(3):193–206
Majumder MTH, Akter A, Li X (2017) Corporate governance and corporate social disclosures: a meta-analytical review. Int J Account Inf Manag 25(4):434–458
Mallin CA, Michelon G (2011) Board reputation attributes and corporate social performance: an empirical investigation of the US best corporate citizens. Account Bus Res 41(2):119–144
Marques ICP, da Silva ZM, Teixeira S, Nogueira FMD (2020) Corporate governance and the environment in the health sector: systematic literature review. J Gov Regul 9(2):8–33
McPherson M, Smith-Lovin L, Cook JM (2001) Birds of a feather: homophily in social networks. Annu Rev Sociol 27:415–444
Millar R, Mannion R, Freeman T, Davies HT (2013) Hospital board oversight of quality and patient safety: a narrative review and synthesis of recent empirical research. Milbank Q 91(4):738–770
Miras-Rodríguez MD, Martínez-Martínez D, Escobar-Pérez B (2018) Which corporate governance mechanisms drive CSR disclosure practices in emerging countries? Sustainability 11(1):61–80
Murphy D, McGrath D (2013) ESG reporting-class actions, deterrence, and avoidance. Sustain Account Manag Policy J 4(2):216–235
Muttakin MB, Subramaniam N (2015) Firm ownership and board characteristics: do they matter for corporate social responsibility disclosure of Indian companies? Sustain Account Manag Policy J 6(2):138–165
Naciti V (2019) Corporate governance and board of directors: the effect of a board composition on firm sustainability performance. J Clean Prod 237:117727
Ongsakul V, Jaroenjitrkam A, Treepongkaruna S, Jiraporn P (2022) Does board gender diversity reduce ‘CEO luck’? Account Finance 62(1):243–260
Pandya D, Kumar G (2022) Applying industry 4.0 technologies for the sustainability of small service enterprises. Serv Bus. https://doi.org/10.1007/s11628-022-00507-7
Paolone F, Cucari N, Wu J, Tiscini R (2021) How do ESG pillars impact firms’ marketing performance? A configurational analysis in the pharmaceutical sector. J Bus Ind Mark 37(8):1594–1606
Pérez-Calero L, Hurtado-González JM, Giráldez-Puig P (2018) Board attributes and corporate social responsibility disclosure: a meta-analysis. Sustainability 10(12):4808
Prybil LD, Popa GJ, Warshawsky NE, Sundean LJ (2019) Build the case for including nurse leaders on healthcare organization boards. Nurs Econ 37(4):169–197
PWC (2021) Beyond compliance: consumers and employees want business to do more on ESG. PWC. https://www.pwc.com/us/en/services/consulting/library/consumer-intelligence-series/consumer-and-employee-esg-expectations.html. Assessed 16 Jan 2022
Qa’dan MBA, Suwaidan MS (2019) Board composition, ownership structure and corporate social responsibility disclosure: the case of Jordan. Soc Responsib J 15(1):28–46
Rediker KJ, Seth A (1995) Boards of directors and substitution effects of alternative governance mechanisms. Strateg Manag J 16(2):85–99
Russo F (2016) What is the CSR’s focus in healthcare? J Bus Ethics 134(2):323–334
Sajko M, Boone C, Buyl T (2021) CEO greed, corporate social responsibility, and organizational resilience to systemic shocks. J Manag 47(4):957–992
Salvi A, Petruzzella F, Raimo N, Vitolla F (2022) The relationship between ESG disclosure and the cost of debt in the healthcare industry. In: Handbook of research on healthcare standards, policies and reform. IGI Global, Hershey, pp 75–90
Schaltegger S, Zvezdov D (2015) Gatekeepers of sustainability information: exploring the roles of accountants. J Account Organ Change 11(3):333–361
Sehrawat NK, Singh S, Kumar A (2020) Does corporate governance affect financial performance of firms? A large sample evidence from India. Bus Strategy Dev 3(4):615–625
Shankar D, Ahsanuddin S (2019) It’s time for the health care system to reckon with the human costs of climate change. https://www.healthaffairs.org/do/. Assessed 8 July 2021
Sharif M, Rashid K (2014) Corporate governance and corporate social responsibility (CSR) reporting: an empirical evidence from commercial banks (CB) of Pakistan. Qual Quant 48(5):2501–2521
Shaukat A, Qiu Y, Trojanowski G (2016) Board attributes, corporate social responsibility strategy, and corporate environmental and social performance. J Bus Ethics 135(3):569–585
Siniora D (2017) Corporate social responsibility in the health care sector. In: Graduate student research symposium, 2017. Duquesne University
Southwick R (2022) Pop culture: why hospitals should emulate Coca-Cola in sustainability reporting. https://www.chiefhealthcareexecutive.com/view/pop-culture-why-hospitals-should-emulate-coca-cola-in-sustainability-reporting. Assessed 16 Jan 2023
Sterbenk Y, Champlin S, Windels K, Shelton S (2022) Is femvertising the new greenwashing? Examining corporate commitment to gender equality. J Bus Ethics 177(3):491–505
Stockham M (2013) Split Decisions: The Pros and Cons of Separating CEO and Chairman Roles. Corporate Compliance Insights. https://www.corporatecomplianceinsights.com/split-decisions-the-pros-and-cons-of-separating-ceo-and-chairman-roles/. Accessed 10 Jul 2021
Tehemar SZ (2012) Corporate social responsibility in healthcare. https://www.healthworkscollective.com/corporate-social-responsibility-healthcare-sectors/. Assessed 6 July 2022
Thiel A, Winter V, Büchner VA (2018) Board characteristics, governance objectives, and hospital performance: an empirical analysis of German hospitals. Health Manag Rev 43(4):282–292
Torchia M, Calabrò A (2018) Increasing the governance standards of public–private partnerships in healthcare. Evidence from Italy. Public Organ Rev 18(1):93–110
Tosi HL, Katz JP, Gomez-Mejia LR (1997) Disaggregating the agency contract: the effects of monitoring, incentive alignment, and term in office on agent decision making. Acad Manag J 40(3):584–602
Tuan LT (2012) Corporate social responsibility, leadership, and brand equity in healthcare service. Soc Responsib J 8(3):347–362
Uppal N (2020) CEO narcissism, CEO duality, TMT agreeableness and firm performance: an empirical investigation in auto industry in India. Eur Bus Rev 32(4):573–590
Uyar A, Kuzey C, Kilic M, Karaman AS (2021) Board structure, financial performance, corporate social responsibility performance, CSR committee, and CEO duality: disentangling the connection in healthcare. Corp Soc Responsib Environ Manag 28(6):1730–1748
Valenti A, Horner S (2020) The human capital of boards of directors and innovation: an empirical examination of the pharmaceutical industry. Int J Innov Manag 24(06):2050056
Velte P (2019) Do CEO incentives and characteristics influence corporate social responsibility (CSR) and vice versa? A literature review. Soc Responsib J 16(8):1293–1323
Vitolla F, Raimo N, Rubino M (2020) Board characteristics and integrated reporting quality: An agency theory perspective. Corp Soc Responsib Environ Manag 27(2):1152–1163
Wei S, Sial MS, Zhou W, Badulescu A, Badulescu D (2021) Improving the environmental footprint through employees: a case of female leaders from the perspective of CSR. Int J Environ Res Public Health 18(24):13082
Weingast BR (2013) Why developing countries prove so resistant to the rule-of-law. In: Global perspectives on the rule of law. Routledge-Cavendish, Abingdon, pp 44–68
Wijethilake C, Ekanayake A (2020) CEO duality and firm performance: the moderating roles of CEO informal power and board involvements. Soc Responsib J 16(8):1453–1474
Wong WP, Hazlina Ahmad N, Mohamad MN (2014) The impact of external environmental on business process management and organizational performance. Serv Bus 8(4):559–586
Yuan Y, Tian G, Lu LY, Yu Y (2019) CEO ability and corporate social responsibility. J Bus Ethics 157(2):391–411
Zhang JQ, Zhu H, Ding HB (2013) Board composition and corporate social responsibility: An empirical investigation in the post Sarbanes-Oxley era. J Bus Ethics 114(3):381–392
Zhu Q, Johnson S, Sarkis J (2018) Lean six sigma and environmental sustainability: a hospital perspective. Supply Chain Forum Int J 19(1):25–41
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gu, V.C. How independent should a board be? Examine the corporate social responsibility performance in the US healthcare sector. Serv Bus 17, 695–721 (2023). https://doi.org/10.1007/s11628-023-00523-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11628-023-00523-1